Revathy Sampath-Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Revathy Sampath-Kumar has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Ehtisham Mahmud
8 shared publicationsOri Ben-Yehuda
Division of Cardiovascular Medicine, University of California San Diego, La Jolla, California, USA
5 shared publications- Ori Ben-Yehuda
University of California, San Diego (O.B.-Y., D.E.).
5 shared publications Anna Melendez
UCSD Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, La Jolla, California, USA
4 shared publicationsLawrence Ang
UCSD Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, La Jolla, California, USA
4 shared publications- Ryan Reeves
Sulpizio Cardiovascular Center, University of California San Diego, La Jolla, CA, USA
4 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (12)
Congestion Assessed With Inferior Vena Cava Ultrasound Predicts Long-Term Outcomes in Acute Decompensated Heart Failure
- 18 November 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (12)
Open AccessCongestion Assessed With Inferior Vena Cava Ultrasound Predicts Long-Term Outcomes in Acute Decompensated Heart Failure
- 13 July 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (13) , 1793-1795
Lumen Versus Limb
- 13 July 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (13) , 1793-1795
Lumen Versus Limb
- Open Access
- 19 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (7) , 102881
Left Ventricular Ejection Fraction Trajectory and Long-Term Outcomes Following Percutaneous Coronary Intervention for Myocardial Infarction
- 19 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (7) , 102881
Open AccessLeft Ventricular Ejection Fraction Trajectory and Long-Term Outcomes Following Percutaneous Coronary Intervention for Myocardial Infarction
- Open Access
- 27 May 2026
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 12, e14
Valvular Heart Disease in Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) is associated with reduced functional capacity and quality of life, as well as with high rates of heart failure hospitalisation and mortality. Valvular heart disease (VHD) is frequently encountered in patients with HFpEF, and both conditions share common risk factors, such as age, hypertension, diabetes and coronary artery disease, which may contribute to their shared pathogenesis and progression. With recent advances in percutaneous therapies for VHD and an improved understanding of HFpEF, there is a growing interest in the relationship between VHD and HFpEF. In this review, we provide an overview of the pathophysiology, epidemiology and management strategies of tricuspid regurgitation, mitral regurgitation, aortic stenosis and aortic regurgitation in the setting of HFpEF.
- 27 May 2026
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 12, e14
Open AccessValvular Heart Disease in Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) is associated with reduced functional capacity and quality of life, as well as with high rates of heart failure hospitalisation and mortality. Valvular heart disease (VHD) is frequently encountered in patients with HFpEF, and both conditions share common risk factors, such as age, hypertension, diabetes and coronary artery disease, which may contribute to their shared pathogenesis and progression. With recent advances in percutaneous therapies for VHD and an improved understanding of HFpEF, there is a growing interest in the relationship between VHD and HFpEF. In this review, we provide an overview of the pathophysiology, epidemiology and management strategies of tricuspid regurgitation, mitral regurgitation, aortic stenosis and aortic regurgitation in the setting of HFpEF.
- Open Access
- 6 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102724
Accelerating Testosterone Prescribing for U.S. Women
- 6 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102724
Open AccessAccelerating Testosterone Prescribing for U.S. Women
- 1 April 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (4) , e013056
Peripartum Cardiogenic Shock From Effusive-Constrictive Pericarditis Requiring VA-ECMO and Pericardiectomy
- 1 April 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (4) , e013056
Peripartum Cardiogenic Shock From Effusive-Constrictive Pericarditis Requiring VA-ECMO and Pericardiectomy
- Open Access
- 20 January 2026
- Published by Elsevier in Structural Heart
- Vol. 10 (3) , 100783
Letter to the Editor Response
- 20 January 2026
- Published by Elsevier in Structural Heart
- Vol. 10 (3) , 100783
Open AccessLetter to the Editor Response
- Open Access
- 28 October 2025
- Published by Elsevier in Structural Heart
- Vol. 10 (1) , 100741
The Impact of Prosthesis-Patient Mismatch on Bioprosthetic Valve Durability After Transcatheter Aortic Valve Replacement
- 28 October 2025
- Published by Elsevier in Structural Heart
- Vol. 10 (1) , 100741
Open AccessThe Impact of Prosthesis-Patient Mismatch on Bioprosthetic Valve Durability After Transcatheter Aortic Valve Replacement
- Open Access
- 22 October 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (11) , 102247
Impact of Triglycerides and Remnant Particles on Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement
- 22 October 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (11) , 102247
Open AccessImpact of Triglycerides and Remnant Particles on Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement